Dr. Saurav Chatterjee, FACC, MD

Dr. Chatterjee practices at New York Heart and Vascular Care in Old Westbury, New York.

Dr. Chatterjee's NPI, 1295963072, was assigned on June 30, 2009. Dr. Chatterjee holds New York license 274314-1.

Dr. Chatterjee's primary practice is New York Heart and Vascular Care, at 1 Store Hill Rd, Old Westbury, NY 11568 in Nassau County. The practice phone is (347) 480-5287.

Dr. Chatterjee's primary practice is New York Heart and Vascular Care in Old Westbury, New York. Dr. Chatterjee is also affiliated with Tisch Hospital. The medical group on file is New York Heart and Vascular Care. Dmand AI also links Dr. Chatterjee to 1 more hospital, 15 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chatterjee practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Chatterjee's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Chatterjee's licenses on file in 2 states: New York and Connecticut.

CMS data shows 66 Medicare services from Dr. Chatterjee across 2 procedure codes in 2024, for 73 Medicare patients. Medicare paid $1,149 for them.

CMS counts 73 Medicare patients who saw Dr. Chatterjee in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 64% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chatterjee's median patient age at 62, with 49% women.

In 2024, Dr. Chatterjee wrote 823 Medicare Part D claims for 200 patients. 92% of them were for generic drugs. CMS names the drug for 694 of them, across 13 drugs with 11 or more claims each, at $13,070 in total drug cost. In 2023, CMS named 218 claims across 13 drugs.

Dr. Chatterjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Chatterjee, more than 33% of the clinicians it reports for that procedure.

Dmand AI links 212 papers to Dr. Chatterjee, published from 2011 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Randomized Controlled Trials as Topic, Percutaneous Coronary Intervention and Anticoagulants. Dr. Chatterjee has published most often in Catheter Cardiovasc Interv. Dr. Chatterjee's most frequent co-authors are Partha Sardar, MD, Debabrata P. Mukherjee, MD and Chirag Pankajkumar Bavishi, MD, MPH.

CMS Open Payments shows 170 general payments to Dr. Chatterjee from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Abbott Laboratories paid the most, $29,115.